{'output': [['Regeneron Pharmaceuticals Inc', 'COMP', 'Announce', 'gene sequencing project', 'EVENT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Form', 'consortium', 'ORG'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Collaborate_With', 'rival drugmakers', 'COMP'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Operate_In', 'UK Biobank database', 'GPE'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Control', 'genetic information', 'CONCEPT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Impact', 'new drug discovery', 'CONCEPT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Impact', 'approval success rates', 'CONCEPT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Make_Available', 'data', 'CONCEPT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Has', 'exclusive access', 'CONCEPT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Relate_To', 'health researchers', 'PERSON'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Fund', 'exome sequencing', 'EVENT'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Operate_In', 'end of 2019', 'TIME'], ['Regeneron Pharmaceuticals Inc', 'COMP', 'Original_Timeline', '2022', 'TIME'], ['Pfizer Inc', 'COMP', 'Contribute', '$10 million', 'MONEY'], ['AbbVie Inc', 'COMP', 'Contribute', '$10 million', 'MONEY'], ['AstraZeneca Plc', 'COMP', 'Contribute', '$10 million', 'MONEY'], ['Biogen', 'COMP', 'Contribute', '$10 million', 'MONEY'], ['Alnylam Pharmaceuticals Inc', 'COMP', 'Contribute', '$10 million', 'MONEY'], ['Exome', 'CONCEPT', 'Contain', 'coding genes', 'CONCEPT'], ['Exome', 'CONCEPT', 'Used_As', 'targets for medicines', 'CONCEPT'], ['George Yancopoulos', 'PERSON', 'President', 'Regeneron Pharmaceuticals Inc', 'COMP'], ['George Yancopoulos', 'PERSON', 'Chief_Scientific_Officer', 'Regeneron Pharmaceuticals Inc', 'COMP'], ['George Yancopoulos', 'PERSON', 'Said', 'telephone interview', 'EVENT'], ['Industry', 'CONCEPT', 'Failure_Rates', 'too high', 'CONCEPT'], ['Healthcare costs', 'CONCEPT', 'high', 'CONCEPT'], ['Genetically validated targets', 'CONCEPT', 'Higher_Success_Rate', 'CONCEPT'], ['U.S. National Institutes of Health', 'ORG/GOV', 'Make_Discoveries', 'CONCEPT'], ['Academic researchers', 'PERSON', 'Make_Discoveries', 'CONCEPT'], ['Sequencing capacity', 'CONCEPT', 'Double', 'year', 'TIME'], ['UK Biobank', 'GPE', 'Partner', 'gene sequencing project', 'EVENT'], ['UK Biobank', 'GPE', 'Compile', 'medical data', 'CONCEPT'], ['UK Biobank', 'GPE', 'Have', 'whole-body imaging', 'CONCEPT'], ['UK Biobank', 'GPE', 'Have', 'periodic MRI scans', 'CONCEPT'], ['UK Biobank', 'GPE', 'Have', 'primary care information', 'CONCEPT'], ['George Yancopoulos', 'PERSON', 'Acknowledge', 'limits to genetic variations', 'CONCEPT'], ['George Yancopoulos', 'PERSON', 'Hope', 'spur similar large-scale efforts', 'EVENT'], ['George Yancopoulos', 'PERSON', 'Looking_For', 'other big projects', 'EVENT'], ['George Yancopoulos', 'PERSON', 'Think', 'great model', 'CONCEPT']]}